Skip to content

Automated High-Throughput Ligand-Detected NMR for Medicinal Chemistry Hit Triage and Binding Assessment.

Sep 2026 · Journal of Medicinal Chemistry · Vol 69 19, pp. 22565-22573 · 0 citations · 28 references
Medicine

TL;DR

A fully automated, ligand-detected high-throughput NMR (HT-NMR) workflow, applicable to aromatic-ring-containing compounds common to high throughput screening libraries, which delivers compound triage and binding assessment.

Abstract

Early discovery campaigns routinely generate screening hits whose progression is limited by uncertain aqueous solubility, chemical integrity, and target engagement. We report a fully automated, ligand-detected high-throughput NMR (HT-NMR) workflow, applicable to aromatic-ring-containing compounds common to high throughput screening libraries, which delivers compound triage and binding assessment. Automated Echo/Tecan sample preparation is validated by Artel calibration and qNMR benchmarking, and band-selective SOFAST experiments centered on the aromatic region enable rapid acquisition in assay buffers. qNMR-SOFAST quantifies aqueous concentrations and flags degradation/impurities, while PE CPMG-SOFAST and STD-SOFAST provide orthogonal target engagement readouts. Python-based tools automate processing, analysis, and reporting. Ligand signals are detected down to 20 μM with quantitation error <25%, allowing binding decisions to be made from as few as four paired samples, <100 μg, per compound. A three-tier decision framework classifies hits by confidence and directs follow-up to orthogonal assays for affinity estimation, accelerating triage and reducing false progression.

View source

Similar papers

Open access Sep 2026

PROXINAUT: An Automation Platform for Rapid Hit-to-Degrader Discovery

Massive library-based platforms enable rapid early hit discovery, yet subsequent hit resynthesis and validation remain major bottlenecks in drug discovery. This delay is amplified when optimizing hits, or elaborating structures towards more advanced modalities, such as chemical inducers of proximity (CIPs). Here, we re...

Sean M. McKenna, Monika Gnatzy, Edith van der Nol et al. · 0 citations
Oct 2026

A fine-tuning-guided virtual screening workflow identifies cell-active small-molecule hits targeting Gq-mediated signaling.

Gq protein represents a critical signaling node in GPCR pathways, its abnormal activation relates with various diseases, including uveal melanoma and cardiovascular disorders. However, existing Gq inhibitors suffer from structural complexity and poor drug-like properties, while traditional screening methods have proven...

Zi-Yang Wu, Xin Chen, Hang Su et al. · 0 citations
Open access Oct 2026

Prospective discovery of LasB inhibitors by integrating generative design, free energy ranking, and experimental validation

Identifying synthetically accessible, potent ligands from vast chemical space remains a major challenge in drug discovery, particularly because experimental synthesis and testing are costly and low throughput. Here, we present a fully open-source computational–experimental workflow that integrates fragment-based de nov...

Alejandro Martínez León, Angeliki Vgenopoulou, Gwenaëlle Jézéquel et al. · 0 citations
Open access Sep 2026

A resource-efficient structure-based workflow for fragment progression enables parallel hit discovery and validation of functionally diverse modulators of NCS-1 protein–protein interactions

Efficient drug discovery workflows ideally generate data that directly address key translational milestones, including confirmation of target engagement and binding pose, structure–activity relationships (SARs), and biological relevance, within rapid and resource-efficient experimental cycles. Here, we describe a data-...

D. Muñoz-Reyes, K. Fieseler, M. Winokan et al. · 0 citations
Open access Sep 2026

Confidence-Gated Triage: Coupling Drug–Target Affinity and ADME-T Predictions to Prioritise Compounds for Docking

A transparent pre-screen can prioritise compounds ahead of structure-based calculation at a fraction of its cost, and the uncertainty and applicability-domain terms act as an abstention mechanism rather than an accuracy gain, and that abstention is not free.

Gozde Yalcin Ozkat · 0 citations
Oct 2026

Decoding the Molecular Target Landscape of Chalcones: An Integrated Cheminformatics Analysis Using PubChem Patent Data, Protein Target Profiling, and Bioassay Activity Mapping.

BACKGROUND Chalcones are α,β-unsaturated ketone scaffolds with broad documented bioactivity. No prior study has simultaneously integrated structural validation, PAINS assessment, chemical-space clustering, human-target classification, bioassay hit-rate benchmarking, and patent analysis within a single computational fra...

S. Arulsamy, Kiruthiga Natarajan, S. K. Krishnan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.